116 related articles for article (PubMed ID: 11103926)
1. A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty.
Al MJ; Van Hout BA
Health Econ; 2000 Oct; 9(7):599-609. PubMed ID: 11103926
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data.
Stevens JW; O'Hagan A
Int J Technol Assess Health Care; 2002; 18(4):782-90. PubMed ID: 12602079
[TBL] [Abstract][Full Text] [Related]
3. Popping the cost balloon. Angioplasty study should be a harbinger, but budgets, entropy stall reform.
Sloane T
Mod Healthc; 2007 Apr; 37(15):21. PubMed ID: 17494354
[No Abstract] [Full Text] [Related]
4. Cost analysis between stent and conventional balloon angioplasty.
Kobayashi Y; De Gregorio J; Yamamoto Y; Komiyama N; Miyazaki A; Masuda Y
Jpn Circ J; 2000 Mar; 64(3):161-4. PubMed ID: 10732845
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement. Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group.
Serruys PW; de Bruyne B; Carlier S; Sousa JE; Piek J; Muramatsu T; Vrints C; Probst P; Seabra-Gomes R; Simpson I; Voudris V; Gurné O; Pijls N; Belardi J; van Es GA; Boersma E; Morel MA; van Hout B
Circulation; 2000 Dec; 102(24):2930-7. PubMed ID: 11113042
[TBL] [Abstract][Full Text] [Related]
7. Bayesian estimation of cost-effectiveness ratios from clinical trials.
Heitjan DF; Moskowitz AJ; Whang W
Health Econ; 1999 May; 8(3):191-201. PubMed ID: 10348414
[TBL] [Abstract][Full Text] [Related]
8. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
Claxton K
J Health Econ; 1999 Jun; 18(3):341-64. PubMed ID: 10537899
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.
Bakhai A; Stone GW; Grines CL; Murphy SA; Githiora L; Berezin RH; Cox DA; Stuckey T; Griffin JJ; Tcheng JE; Cohen DJ;
Circulation; 2003 Dec; 108(23):2857-63. PubMed ID: 14610016
[TBL] [Abstract][Full Text] [Related]
10. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial).
Greenberg D; Rosenfield K; Garcia LA; Berezin RH; Lavelle T; Fogleman S; Cohen DJ
J Vasc Interv Radiol; 2004 Oct; 15(10):1065-9. PubMed ID: 15466792
[TBL] [Abstract][Full Text] [Related]
11. Bayesian estimation of cost-effectiveness from censored data.
Heitjan DF; Kim CY; Li H
Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and cost comparison of carotid artery angioplasty with stenting versus carotid endarterectomy.
Park B; Mavanur A; Dahn M; Menzoian J
J Vasc Surg; 2006 Aug; 44(2):270-6. PubMed ID: 16890852
[TBL] [Abstract][Full Text] [Related]
13. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
[TBL] [Abstract][Full Text] [Related]
14. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.
Cohen DJ; Krumholz HM; Sukin CA; Ho KK; Siegrist RB; Cleman M; Heuser RR; Brinker JA; Moses JW; Savage MP
Circulation; 1995 Nov; 92(9):2480-7. PubMed ID: 7586348
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian model averaging approach for cost-effectiveness analyses.
Conigliani C; Tancredi A
Health Econ; 2009 Jul; 18(7):807-21. PubMed ID: 18792078
[TBL] [Abstract][Full Text] [Related]
16. Bayesian cost-effectiveness analysis from clinical trial data.
O'Hagan A; Stevens JW; Montmartin J
Stat Med; 2001 Mar; 20(5):733-53. PubMed ID: 11241573
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.
Cohen DJ; Breall JA; Ho KK; Kuntz RE; Goldman L; Baim DS; Weinstein MC
Circulation; 1994 Apr; 89(4):1859-74. PubMed ID: 8149551
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian approach to stochastic cost-effectiveness analysis.
Briggs AH
Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
[TBL] [Abstract][Full Text] [Related]
19. Bayesian estimation of cost-effectiveness: an importance-sampling approach.
Heitjan DF; Li H
Health Econ; 2004 Feb; 13(2):191-8. PubMed ID: 14737756
[TBL] [Abstract][Full Text] [Related]
20. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
O'Hagan A; Stevens JW
Health Econ; 2003 Jan; 12(1):33-49. PubMed ID: 12483759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
